Study of EC0489 for the Treatment of Refractory or Metastatic Tumors

NCT00852189 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
65
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Endocyte